Changes

Jump to navigation Jump to search

Arrhythmogenic Right Ventricular Cardiomyopathy

No change in size, 00:05, 28 January 2010
no edit summary
'''Treatment''' focuses on avoiding complications.<cite>ACC2006</cite>
*Medication:
**antiAnti-arrhythmics: Sotalol better than Amiodarone.
**ACE-inhibitors to prevent cardiac remodelling
*[[ICD]] implantation is recommended for the prevention of sudden cardiac death in patients with ARVC with documented sustained VT or VF who are receiving chronic optimal medical therapy.
*[[ICD]]] implantation can be considered for the prevention of sudden cardiac death in patients with ARVC with extensive disease, including those with left ventricular involvement, 1 or more affected family member with SCDICD, or undiagnosed syncope when [[Ventricular Tachycardia|ventricular tachycardia]] or [[Ventricular Fibrillation|ventricular Fibrillation]] has not been excluded as the cause of syncope, who are receiving chronic optimal medical therapy, and who have reasonable expectation of survival with a good functional status for more than 1 y.
*Radiofrequency [[ablation]] can be useful as adjunctive therapy in management of patients with ARVC with recurrent [[Ventricular Tachycardia|ventricular tachycardia]], despite optimal antiarrhythmic drug therapy.
114

edits

Navigation menu